Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

ยฉ 2026 Go Backs. All rights reserved.

Medium RiskFDA Device
Medical Devices/Home Healthcare

Embecta Corp.: BD Nano 2nd Gen Pen Needles Recalled for Potential Lack of Sterility

Agency Publication Date: July 23, 2024
Share:
Sign in to monitor this recall

Summary

Embecta Corp. is recalling approximately 185,900 BD Nano 2nd Gen Pen Needles because they were shipped close to or after their labeled expiration date of February 29, 2024. These sterile, single-use needles are used with drug pen injectors to deliver medications. The affected needles were distributed nationwide in the United States and were often included in 'Patient Counseling Sample Toolboxes.' Consumers should check their supplies for the specific lot number 9044773 or toolbox lot 3750144 to ensure they are not using expired medical devices.

Risk

Using these medical devices past their expiration date means that the sterility and physical integrity of the needle cannot be guaranteed. This could potentially lead to infections or improper drug delivery if the needle is compromised or no longer sterile.

What You Should Do

  1. Check your medical supplies for BD Nano 2nd Gen Pen Needles (32G x 4mm) with Lot Number 9044773 and an expiration date of 2024/02/29.
  2. Verify if you have a 'Patient Counseling Sample Toolbox' (Catalog/Marketing Reference Number 6484755) with Lot Number 3750144, as these contain the affected needles.
  3. Immediately stop using any needles identified with these specific lot numbers and expiration dates.
  4. Contact your healthcare provider or Embecta Corp. at 1-888-463-6332 for further instructions on how to return the expired product and to obtain safe replacements.
  5. If you have experienced any health issues after using these needles, contact your doctor or pharmacist immediately.
  6. For additional questions, call the FDA hotline at 1-888-463-6332 (1-888-INFO-FDA) or visit www.fda.gov/medical-devices/medical-device-recalls.

Your Remedy Options

๐Ÿ“‹Other Action

Consult healthcare provider or manufacturer

How to: Contact your healthcare provider or the manufacturer for further instructions and potential refund

Affected Products

Product: BD Nano 2nd Gen Pen Needles 32G X 4mm (5-count sample)
Model / REF:
320551
6484755
Lot Numbers:
9044773 (Exp 2024/02/29)
3750144
Date Ranges: February 29, 2024

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 94851
Status: Active
Manufacturer: Embecta Corp.
Sold By: Healthcare providers; Authorized distributors
Manufactured In: United States
Units Affected: 185900
Distributed To: Nationwide

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES ยท Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.